Pharmalink AB Receives US Orphan Drug Designation for Nefecon® (PL-56) October 13, 2010 15:14 CET Non Regulatory Read more
Grifols agrees to acquire intellectual property for treatment of post-polio syndrome from Pharmalink AB May 20, 2010 15:13 CET Non Regulatory Read more